| (EUR) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 37.08B | — |
| Operating expense | — | — |
| Net income | 100.00M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, KOY.F returned +53.3% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -291.3% |
| 1 year | +53.3% |
| 5 years | +752523.8% |
| 10 years | +5055222404.7% |
| All-time high | €98.00 (Nov 2020) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what €1,000 in KOY.F would be worth today ›Yes. Kobayashi Pharmaceutical Co., Ltd. paid 2 dividends over the past 12 months. The most recent was €0.24 per share on Jun 29, 2026. The dividend yield is 1.96%.
Kobayashi Pharmaceutical Co., Ltd. is part of the Consumer Defensive sector.
Kobayashi Pharmaceutical Co., Ltd. has a market cap of 2.20B EUR, based on the latest quote.
